Related Experiment Video
Updated: May 10, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Endothelial dysfunction associated with mild cognitive impairment in elderly population
Gianluigi Vendemiale1, Antonino D Romano, Mariangela Dagostino
1Department of Medical and Surgical Sciences, Institute of Geriatrics, University of Foggia, Foggia, Italy. g.vendemiale@unifg.it
Background And Aims:
According to the original Petersen criteria, we investigated the association between endothelial dysfunction and mild cognitive impairment (MCI) by flow-mediated dilation (FMD). We aimed to verify if endothelial dysfunction occurs in MCI and whether vascular factors are implicated in the MCI pathogenesis.
Methods:
This is a cross-sectional study performed on 34 subjects with clinical diagnosis of MCI and 37 controls, older than 60 years. Patients were enrolled from a geriatric outpatient clinic. All the recognized cardiovascular risk factors and an objective state of cognitive impairment were used as exclusion criteria. Cognitive function was evaluated using a scientific-validated neuropsychological battery, whereas MCI was recognized according to the Petersen criteria. Endothelial function was evaluated according to FMD from the brachial artery. The association between FMD and MCI was evaluated both by using a multivariate analysis and a correlation test. Finally, using the ANOVA analysis of variance, we tested the differences in flow-mediated dilation among MCI subgroups.
Results:
Brachial FMD was significantly associated with MCI (p < 0.01). The multivariate analysis showed that age, years of education and MMSE independently predicted the FMD variation (r (2) = 0.73; p < 0.0001). In addition, MCI patients with prevalent amnestic multiple domain impairment showed the worst brachial FMD.
Conclusions:
This finding suggests that vascular dysfunction may play a role in the pathogenesis of cognitive impairment and underlines the lack of therapeutic strategies targeted to such dysfunctions.
Insights
Endothelial dysfunction, measured by flow-mediated dilation (FMD), is linked to mild cognitive impairment (MCI). This suggests vascular factors contribute to cognitive decline, highlighting a need for targeted therapies.
Area of Science:
- Neuroscience
- Vascular Biology
- Geriatrics
Background:
- Mild cognitive impairment (MCI) is a growing concern in aging populations.
- The role of vascular health, specifically endothelial function, in MCI pathogenesis requires further investigation.
- Endothelial dysfunction may precede or contribute to cognitive decline.
Purpose of the Study:
- To investigate the association between endothelial dysfunction, assessed by flow-mediated dilation (FMD), and mild cognitive impairment (MCI).
- To determine if endothelial dysfunction is present in individuals with MCI.
- To explore the implication of vascular factors in the development of MCI.
Main Methods:
- Cross-sectional study of 67 participants (34 MCI, 37 controls) aged over 60.
- Cognitive function assessed using a validated neuropsychological battery; MCI diagnosed per Petersen criteria.
- Endothelial function evaluated via brachial artery flow-mediated dilation (FMD); statistical analyses included multivariate analysis, correlation, and ANOVA.
Main Results:
- Brachial FMD was significantly associated with MCI (p < 0.01).
- Age, education, and Mini-Mental State Examination (MMSE) scores independently predicted FMD variations (R² = 0.73, p < 0.0001).
- MCI patients with amnestic multiple domain impairment exhibited the poorest brachial FMD.
Conclusions:
- Vascular dysfunction, indicated by impaired FMD, is associated with mild cognitive impairment.
- These findings suggest that endothelial dysfunction may contribute to the pathogenesis of cognitive impairment.
- The results underscore the need for therapeutic strategies targeting vascular dysfunction in cognitive impairment.
Related Concept Videos
Dementia l: Introduction
Cognitive Development During Adulthood
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Hepatic Encephalopathy
Drug Dosing: Geriatric Patients

